American Oncology Network Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| – | – | -103.3% | – | – | – | |
| – | +262.7% | +66.3% | +181.0% | -2.0% | +15.7% | |
| – | – | +0.0% | -3,580.0% | – | +230.0% | |
| – | -230.3% | – | -105.8% | – | – | |
| – | – | -386.8% | – | – | -268.7% | |
| – | +5.2% | -31.9% | -13.6% | +70.8% | +70.6% | |
| – | -30.8% | +2,172.7% | -95.8% | +153.0% | -93.2% | |
| – | – | – | – | – | -96.2% | |
| – | -130.7% | – | -42.9% | -103.7% | +694.3% | |
| – | -58.5% | +1,963.8% | -95.4% | +259.2% | -24.4% | |
| – | – | -97.9% | -775.7% | – | +2,027.1% | |
| – | – | -238.5% | – | – | – |
Data as of: August 19, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.